​
​

Aptose Biosciences Ownership | Who Owns Aptose Biosciences?

OverviewRevenueFinancialsChartTranscripts

Aptose Biosciences Ownership Summary

Aptose Biosciences is owned by 0.39% institutional investors, 15.87% insiders, and 83.74% retail investors. Caldwell sutter capital is the largest institutional shareholder, holding 0.00% of APTO shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Aptose Biosciences shares.

APTO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAptose Biosciences0.39%15.87%83.74%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Caldwell sutter capital92.000.00%$70.00
Doheny asset management /ca---
Annandale capital---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caldwell sutter capital92.00-$70.00
Doheny asset management /ca---
Annandale capital---

Top Buyers

HolderShares% AssetsChange
Caldwell sutter capital92.00--
Annandale capital---26.67K
Doheny asset management /ca---50.55K

Top Sellers

HolderShares% AssetsChange
Doheny asset management /ca---50.55K
Annandale capital---26.67K
Caldwell sutter capital92.00--

Sold Out

HolderChange
Annandale capital-26.67K
Doheny asset management /ca-50.55K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20242-50,64289.26%-245.77%1---100.00%
Mar 31, 20242-26,758-64.21%-29.90%--1-
Dec 31, 20232-74,758-10.36%--100.00%--
Sep 30, 20232-74,75839.93%17540135.36%1---100.00%
Jun 30, 20232-95.74%53,424-99.75%-2.47%1-88.89%1-92.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index2.16K0.01%-
Dimensional Canadian Small Company767.000.00%-
DFA International Small Company I741.000.00%-
DFA Global Small Company Institutional1.00--

Recent Insider Transactions

DateNameRoleActivityValue
Sep 22, 2023Seizinger Bernd R.-Buy$53.38K
Sep 19, 2022Rice William G. Chair, President & CEOBuy$6.83K
Jun 06, 2022Rice William G. Chair, President & CEOBuy$9.68K
Dec 20, 2021BURGER DENIS R-Buy$14.49K
Dec 16, 2021PLATZER ERICH-Buy$28.00K

Insider Transactions Trends

DateBuySell
2027 Q2--
2024 Q1--
2023 Q31-
2023 Q1--
2022 Q31-

APTO Ownership FAQ

Who Owns Aptose Biosciences?

Aptose Biosciences shareholders are primarily institutional investors at 0.39%, followed by 15.87% insiders and 83.74% retail investors. The average institutional ownership in Aptose Biosciences's industry, Biotech Stocks , is 45.43%, which Aptose Biosciences falls below.

Does Blackrock own Aptose Biosciences?

BlackRock is not among the top 10 institutional shareholders of Aptose Biosciences.

Who is Aptose Biosciences’s biggest shareholder by percentage of total assets invested?

Caldwell sutter capital is Aptose Biosciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 92 Aptose Biosciences shares, valued at 70$.

Who is the top mutual fund holder of Aptose Biosciences shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Aptose Biosciences shares, with 0.01% of its total shares outstanding invested in 2.16K Aptose Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools